Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-26.

Estimate momentum

Over six months the cuts run deeper: FY2028 revenue is down ~11% from 180 days ago while normalized EPS fell only ~7% and FY2027 EPS actually rose, with margins and buybacks cushioning a slower top line.

Currency: USD · Scale: money in millions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.

Metric FY 180d 90d 30d Now Δ90d
EPS (normalized) FY2027 $14.76 $14.72 $15.32 $15.31 +4.0%
EPS (normalized) FY2028 $18.72 $16.94 $17.60 $17.48 +3.2%
Revenue FY2027 $7.14bn $6.85bn $6.72bn $6.71bn -2.1%
Revenue FY2028 $7.94bn $7.25bn $7.07bn $7.06bn -2.6%

EPS has topped consensus every quarter on record, often by double digits

Revenue prints land within about a point of consensus in either direction, so the beats are a guidance and earnings-quality story rather than a demand surprise.

Current sequences by metric: Revenue: 1 consecutive miss; EPS (normalized): 8 consecutive beats.

Currency: USD · Scale: money in millions, absolute · Consensus is captured before each actual first became effective.

Quarter Metric Consensus Actual Surprise Outcome
Q1 FY2026 Revenue $1.52bn $1.51bn -0.3% Miss
Q1 FY2026 EPS (normalized) $2.92 $3.32 +13.6% Beat
Q4 FY2025 Revenue $1.75bn $1.75bn +0.2% Beat
Q4 FY2025 EPS (normalized) $3.51 $3.94 +12.2% Beat
Q3 FY2025 Revenue $1.52bn $1.52bn +0.2% Beat
Q3 FY2025 EPS (normalized) $2.43 $2.76 +13.7% Beat
Q2 FY2025 Revenue $1.67bn $1.69bn +0.7% Beat
Q2 FY2025 EPS (normalized) $3.31 $3.53 +6.8% Beat
Q1 FY2025 Revenue $1.53bn $1.53bn -0.0% Miss
Q1 FY2025 EPS (normalized) $2.72 $2.98 +9.7% Beat
Q4 FY2024 Revenue $1.69bn $1.72bn +1.5% Beat
Q4 FY2024 EPS (normalized) $3.26 $5.45 +67.2% Beat
Q3 FY2024 Revenue $1.48bn $1.48bn +0.6% Beat
Q3 FY2024 EPS (normalized) $2.37 $2.50 +5.6% Beat
Q2 FY2024 Revenue $1.58bn $1.60bn +0.7% Beat
Q2 FY2024 EPS (normalized) $3.03 $3.22 +6.4% Beat

Forward estimates

Currency: USD · Scale: money in millions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.

Metric FY2025A FY2026E FY2027E FY2028E FY2029E YoY Analysts Low / high
Revenue $6.49bn $6.43bn $6.71bn $7.06bn $7.12bn 11 $6.48bn / $6.51bn
EBITDA $1.59bn $1.57bn $1.64bn $1.74bn $1.77bn 9 $1.58bn / $1.61bn
EPS (normalized) $12.79 $13.68 $15.31 $17.48 $21.14 12 $12.66 / $12.95

Analysts split on FY2028: normalized EPS spans $15.68 to $21.43

Ten estimates back the FY2028 EPS mean of ~$17.48 but disagree by roughly a third top-to-bottom; the revenue and EBITDA ranges are wide as well.

Currency: USD · Scale: money in millions, absolute · Spread/mean is absolute high-low divided by absolute mean.

Metric Period Mean Low–high Spread/mean Analysts
EPS (normalized) FY2028E $17.48 $15.68–$21.43 32.9% 10
Revenue FY2028E $7.06bn $6.74bn–$7.32bn 8.2% 10
EBITDA FY2028E $1.74bn $1.55bn–$1.84bn 16.8% 10

Street sits on its hands: nine of fourteen at hold, targets from $120 to $203

Currency: USD · Scale: money in millions, absolute · Analyst counts shown explicitly.

Street view Reading Analysts
Recommendation mix Buy 3, Outperform 1, Hold 9, Underperform 1, Sell 1 15
Consensus score 2.73 15
Target price mean $160.4; median $162.0; high $203.0; low $120.0 13

Outer-year coverage thins sharply: FY2029 rests on two analysts

Every FY2029 metric shown is a two-analyst mean, and FY2028 GAAP net income and GAAP EPS draw on only six. Weight the 2027 tape, where counts run 9 to 15, far more heavily.